FDA Surveying U.S. Cosmetic Products For Asbestos-Contaminated Talc
This article was originally published in The Rose Sheet
Executive Summary
FDA is reviewing talc and talc-containing cosmetic products on the U.S. market for asbestos contamination following reports of the carcinogen in cosmetics overseas, according to an FDA spokesman
You may also be interested in...
Heavy Metals, Estrogenics Among Research Priorities For FDA's Cosmetics Office
FDA’s Office of Cosmetics and Colors continues with surveys to detect the presence of controversial ingredients in cosmetics, including asbestos in talc-containing products. Office’s Deputy Director Patricia Hansen provides an overview at the Personal Care Products Council’s recent scientific summit.
FDA: No Asbestos Found In Talc Products Sampled, But Results Limited
Following reports of asbestos in talc and talc-containing products overseas, FDA conducted a survey of suppliers and products on the U.S. market, finding no detectable levels of asbestos.
CIR Expert Panel Set To Make Final Formaldehyde Recommendations Sept. 27
The Cosmetic Ingredient Review Expert Panel could issue a final safety assessment for formaldehyde and methylene glycol at its Sept. 27 meeting.